Results 71 to 80 of about 7,077 (207)

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

Frontiers in Endocrinology
PurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao, Xiaoju Miao, Zhongmin Fu, Zhongmin Fu, Xian Luo, Xian Luo, Jun Wang, Jun Wang, Lili Yuan, Lili Yuan, Shunjun Zhao, Shunjun Zhao, Yi Feng, Shiming Huang, Shunwu Xiao   +14 more
doaj   +1 more source

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma

JACC: Case Reports, 2020
We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD, Jeffrey Le, MD, Shivani Verma, MD, Benjamin A. Youdelman, MD   +3 more
doaj  

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

Indian Journal of Endocrinology and Metabolism, 2017
Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare, Anurag R Lila, Rishikesh Patil, Milind Phadke, Prafulla Kerkar, Tushar Bandgar, Nalini S Shah   +6 more
doaj   +1 more source

Craniopharyngioma with hyperprolactinaemia due to a prolactinoma. [PDF]

, 1986
T Wheatley, J. David Clark, Sheila F. Stewart   +2 more
openalex   +1 more source

Massive prolactinoma with galactorrhoea in a prepubertal boy [PDF]

, 1989
R.J.M. Ross, J M McEniery, Ashley Grossman, I. Doniach, G. M. Besser, Martin O. Savage   +5 more
openalex   +1 more source

Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas. [PDF]

, 1985
K. W. Hancock, J S Scott, J T Lamb, Robert Gibson, C. Chapman   +4 more
openalex   +1 more source

Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients

Gazi Medical Journal
Objective: There may be an association between hyperprolactinemia and autoimmune diseases, possibly because of the immunostimulatory effect of prolactin.
Özlem Kanburoğlu Meletli, Alev Altınova, Başak Bolayır, Resul Karakuş, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, İlhan Yetkin, Füsun Saadet Toruner   +8 more
doaj   +1 more source

Malignant Prolactinoma Discovered by D2 Receptor Imaging [PDF]

, 2000
Patrick Pétrossians, Wouter W. de Herder, Dik J. Kwekkeboom, G. Lamberigts, Achille Stevenaert, Albert Beckers   +5 more
openalex   +2 more sources

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas [PDF]

, 1995
Cristina Missale, Marco Losa, F. Boroni, Massimo Giovanelli, Andrea Balsari, PierFranco Spano   +5 more
openalex   +1 more source

Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients

Open Chemistry, 2019
The present investigation indicates hidden relationships between the several clinical parameters usually monitored on prolactinoma patients using non-hierarchical cluster analysis. The major goal of the chemometric data mining is to offer a possible mode
Nedyalkova Miroslava, Dimitrov Dimitar, Donkova Borjana, Simeonov Vasil   +3 more
doaj   +1 more source